Tr1 cells: from discovery to their clinical application.

[1]  L. Weston,et al.  Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD , 2006, Bone Marrow Transplantation.

[2]  E. Bonifacio,et al.  Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. , 2006, Diabetes.

[3]  L. Zhao,et al.  Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. , 2005, Blood.

[4]  G. Lindahl,et al.  Induction of a Regulatory Phenotype in Human CD4+ T Cells by Streptococcal M Protein1 , 2005, The Journal of Immunology.

[5]  M. Boccadoro,et al.  Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1‐like regulatory T cells , 2005, European journal of immunology.

[6]  C. Hawrylowicz,et al.  Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma , 2005, Nature Reviews Immunology.

[7]  J. Bluestone.  Regulatory T-cell therapy: is it ready for the clinic? , 2005, Nature Reviews Immunology.

[8]  M. Roncarolo,et al.  Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. , 2005, Blood.

[9]  C. Gianfrani,et al.  IL‐10‐Producing T Regulatory Type 1 Cells and Oral Tolerance , 2004, Annals of the New York Academy of Sciences.

[10]  K. Black,et al.  Induction of a CD4+ T Regulatory Type 1 Response by Cyclooxygenase-2-Overexpressing Glioma1 , 2004, The Journal of Immunology.

[11]  T. Ley,et al.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death. , 2004, Immunity.

[12]  B. Stockinger,et al.  IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells 1 , 2004, The Journal of Immunology.

[13]  G. Schuler,et al.  Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals than in Patients with Pemphigus Vulgaris1 , 2004, The Journal of Immunology.

[14]  O. Leavy,et al.  Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent , 2004, Journal of leukocyte biology.

[15]  T. Platts-Mills,et al.  A Role for IL-10-Mediated HLA-DR7-Restricted T Cell-Dependent Events in Development of the Modified Th2 Response to Cat Allergen1 , 2004, The Journal of Immunology.

[16]  R. Barker,et al.  Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. , 2004, Blood.

[17]  Mark Peakman,et al.  Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. , 2004, The Journal of clinical investigation.

[18]  Ming-Tseh Lin,et al.  Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. , 2003, The New England journal of medicine.

[19]  D. Zélénika,et al.  Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms , 2003, Immunological reviews.

[20]  O. Leavy,et al.  Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell Activation 1 , 2003, The Journal of Immunology.

[21]  S. Targan,et al.  CC Chemokine Receptor 9 Expression Defines a Subset of Peripheral Blood Lymphocytes with Mucosal T Cell Phenotype and Th1 or T-Regulatory 1 Cytokine Profile 1 , 2003, The Journal of Immunology.

[22]  A. Enk,et al.  Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. , 2003, Blood.

[23]  H. Groux,et al.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. , 2003, Immunity.

[24]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[25]  K. Murphy,et al.  Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype , 2003, Nature.

[26]  Michel C. Nussenzweig,et al.  Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance , 2002, The Journal of experimental medicine.

[27]  L. Stott,et al.  Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. , 2002, Blood.

[28]  A. Hoerauf,et al.  Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). , 2002, Microbes and infection.

[29]  M. Roncarolo,et al.  Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines , 2002, European journal of immunology.

[30]  G. Rook,et al.  Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells , 2002, Nature Medicine.

[31]  P. Hersey,et al.  Dendritic Cells Heavy Chain Ferritin Activates Regulatory T Cells by Induction of Changes In , 2022 .

[32]  A. Enk,et al.  CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. , 2002, Blood.

[33]  David F. Richards,et al.  In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.

[34]  K. Mills,et al.  Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.

[35]  Michel C. Nussenzweig,et al.  Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.

[36]  H. Groux,et al.  Differentiation of Regulatory T Cells 1 Is Induced by CD2 Costimulation1 , 2001, The Journal of Immunology.

[37]  S W Binder,et al.  CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. , 2001, Gastroenterology.

[38]  R. de Waal Malefyt,et al.  IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1 , 2001, The Journal of Immunology.

[39]  P. Allavena,et al.  Chemokine Receptor Expression and Function in CD4+ T Lymphocytes with Regulatory Activity1 , 2001, The Journal of Immunology.

[40]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[41]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[42]  A. Enk,et al.  Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells , 2000, The Journal of experimental medicine.

[43]  R. Coffman,et al.  T Regulatory Cells 1 Inhibit a Th2-Specific Response In Vivo1 , 2000, The Journal of Immunology.

[44]  Stuart B. Goodman,et al.  Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment , 2000, The Journal of experimental medicine.

[45]  W. Strober,et al.  Activated Self-MHC-Reactive T Cells Have the Cytokine Phenotype of Th3/T Regulatory Cell 1 T Cells , 2000, The Journal of Immunology.

[46]  T. Yonezawa,et al.  Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[47]  C. Albanesi,et al.  Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. , 2000, The Journal of investigative dermatology.

[48]  W. Wilmanns,et al.  Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation , 2000, Bone Marrow Transplantation.

[49]  C. Orosz,et al.  Human allograft acceptance is associated with immune regulation. , 2000, The Journal of clinical investigation.

[50]  M. Roncarolo,et al.  High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths , 1999, Bone Marrow Transplantation.

[51]  I. Bellinghausen,et al.  Do Tr1 Cells Play a Role in Immunotherapy? , 1999, International Archives of Allergy and Immunology.

[52]  P. Allavena,et al.  IL‐10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages , 1998, European journal of immunology.

[53]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[54]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[55]  M. Goldman,et al.  Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes , 1994, European journal of immunology.

[56]  R. de Waal Malefyt,et al.  High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells , 1994, The Journal of experimental medicine.

[57]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[58]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.

[59]  T. Mosmann,et al.  Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[60]  T. Mosmann,et al.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.

[61]  G. Möller.  Do Suppressor T Cells Exist? , 1988, Scandinavian journal of immunology.

[62]  B. Benacerraf,et al.  Suppressor cells and immunoregulation. , 1984, Annual review of immunology.

[63]  R. Gershon,et al.  Infectious immunological tolerance. , 1971, Immunology.